Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study on Botulinum Toxin A for Tinnitus in Patients with Bruxism or Jaw Muscle Pain
NorwayStudy of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment
BelgiumStudy on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis
FranceStudy on the Effects of ILB and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)
NorwayStudy of glycerol phenylbutyrate (oral liquid) for treatment of fatigue in patients with pyruvate dehydrogenase deficiency
FranceStudy on the Effects of EH-301, N-Acetylcysteine, and Riluzole in Patients with Amyotrophic Lateral Sclerosis (ALS)
SpainStudy on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders
DenmarkTitle: Evaluation of lorazepam, pregabalin, and olanzapine in treating agitated behavior in dementia patients who did not respond to standard treatments
The NetherlandsStudy on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer's Disease
AustriaStudy on Sumatriptan and Rimegepant for Treating Nitroglycerin-Induced Headaches in Patients with Episodic Migraine
SpainStudy of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer's disease
BelgiumStudy of Gefurulimab for Children and Teens with Generalized Myasthenia Gravis
PolandThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
